OTC Drugs, Medical Devices and Diagnostics Market to Hit $359.7 Billion by 2029
'Rising chronic disease burden and increased health awareness are driving significant growth in the global OTC drugs, medical devices and diagnostics market.'
BOSTON, April 24, 2025 /PRNewswire/ — BCC Research reveals in its new report, OTC Drugs, Medical Devices, and Diagnostics: Global Markets, the over-the-counter drugs, medical devices and diagnostics market is estimated to grow to $359.7 billion by 2029 at a compound annual growth rate (CAGR) of 7.4% for the forecast period. The rising prevalence of chronic diseases and heightened health awareness following the COVID-19 pandemic are propelling this global market.
This indepth analysis categorizes OTC products by pharmaceutical drugs, vitamin and mineral supplements and various devices and diagnostics for disease management, including monitoring, therapeutic and diagnostic kits. The market is further segmented by application to include a range of health issues such as respiratory, orthopedic, gastrointestinal, cardiovascular, ENT, skin and sleep disorders, as well as diabetes and obesity.
Covering a wide range of OTC products and applications, the report highlights industry advancements, relevant patents and the regulatory landscape. For instance, companies like Apple and Samsung are acquiring regulatory approvals, which could revolutionize the wearable devices sector and significantly enhance OTC disease monitoring.
Factors Driving the Market:
Chronic diseases and aging population: The rise in chronic disease prevalence and an aging population increase the demand for OTC drugs, medical devices, and diagnostics.
Health awareness: People are more aware of health maintenance and disease prevention, driving demand for OTC products and diagnostics.
Online sales and telehealth: E-commerce and telehealth platforms make healthcare products and services more accessible, boosting market growth.
Request a sample copy of the OTC Drugs, Medical Devices, and Diagnostics: Global Markets report.
Report Synopsis
Report Metric
Details
Base year considered
2023
Forecast period considered
2024-2029
Base year market size
$236.8 billion
Market size forecast
$359.7 billion
Growth rate
CAGR of 7.4% for the forecast period of 2024-2029
Segments covered
Product, application
Countries/Regions Covered
North America, Europe, Asia-Pacific, Rest of the World — including U.S., Canada, Germany, U.K., France, Italy, Spain, Switzerland, Denmark, Norway, Poland, Belgium, Austria, the Netherlands, Sweden, Russia, Lithuania, Latvia, Hungary, Slovakia, China, India, Japan, Australia, South Korea, Singapore, Malaysia, New Zealand, Thailand, the Philippines, Vietnam, Indonesia, South America, the Middle East, and Africa
Market drivers
• Growing prevalence of chronic diseases and expanding geriatric populations
• Increasing health awareness
• Growing online sales channels and telehealth platforms
Industry Facts:
The U.S. FDA approved the Apple Watch's AFib feature in 2024, integrating wearable tech into clinical trials. This development revolutionizes OTC devices by empowering consumers and advancing real-time, noninvasive health monitoring for medical research.
Leading global pharmaceutical companies are spinning off their consumer health businesses. This shift allows them to focus on core biopharma operations, allocate resources more effectively, adopt flexible business models, and better serve customers.
The OTC drugs, medical devices, and diagnostics market is a multibillion-dollar industry. Fragmented with a mix of multinational and smaller companies, each segment has its own unique players.
Emerging Startups
NOWDiagnostics develops and manufactures 'Touch to Test' over-the-counter and point-of-care diagnostic tests that deliver results in minutes. The company's patented technology enables accurate onsite immunological assays using a minimal amount of capillary blood or saliva.
Vitable is a health and wellness startup that offers personalized vitamin and customized supplement and vitamin packs tailored to individual needs and delivered directly to customers.
Valencell plans to launch the Fingertip Blood Pressure Monitor, the world's first OTC device to measure blood pressure from the finger without a cuff.
Questions Addressed:
1. What is the projected market size and growth rate of the OTC drugs, medical devices and diagnostics market?
• The global OTC drugs, medical devices and diagnostics market is expected to grow at a compound annual growth rate (CAGR) of 7.4% to reach $359.7 billion by 2029 from $251.7 billion in 2024.
2. Which segments are covered in the report?
• The market is segmented based on product, application and region.
3. Which product segment will dominate the market by the end of 2029?
• The OTC drugs segment will dominate the market by the end of 2029.
4. Which region has the largest market share?
• North America holds the largest share.
Market Leaders:
Koninklijke Philips N.V.
Masimo
Nestle
Procter & Gamble
Sanofi
Abbott
Bayer
Dsm-firmenich
Haleon Group of Companies
Kenvue
Related Reports:
Nutraceuticals: Global Markets: The report analyzes the market shares of leading companies in the nutraceuticals market. It segments the market by product type into functional beverages, food, and dietary supplements. Applications include sports and energy, weight management, general wellness, heart health, gastrointestinal (GI) and digestive health. Distribution channels are categorized by e-commerce, supermarkets, pharmacies, retail stores, and other distribution channels. Regional estimates cover North America, Europe, Asia-Pacific, and the Rest of the World.
Wearable Medical Devices: Technologies and Global Markets: This research report covers the global market for wearable medical devices, segmented by product, application, and sales channel. It includes an in-depth analysis of market estimations and trends. The market is divided into North America, Europe, Asia-Pacific, and Rest of the World (RoW). The report discusses major players, technologies, applications, market dynamics and geographic opportunities and examines analytical frameworks like PESTEL, ESG, regulatory landscape, reimbursement scenario, and competitive analysis to aid strategic planning.
Directly purchase a copy of this report from BCC Research.
For further information or any of these reports or to make a purchase, please contact info@bccresearch.com.
About BCC Research
BCC Research market research reports provide objective, unbiased measurement, and assessment of market opportunities. Our experienced industry analysts' goal is to help you make informed business decisions free of noise and hype.
Contact Us
Corporate HQ: 50 Milk St. Ste 16, Boston, MA 02109, USA
Email: info@bccresearch.com
Phone: +1 781-489-7301
For media inquiries, email press@bccresearch.com or visit our media page for access to our market research library.
Any data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher.
Logo – https://mma.prnewswire.com/media/2183242/5286130/BCC_Research_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/otc-drugs-medical-devices-and-diagnostics-market-to-hit-359-7-billion-by-2029–302437773.html
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Malaysian Reserve
an hour ago
- Malaysian Reserve
U.S. Legal Support Recognized as #1 Document Management Solution for Retrieved Records in The Recorder's Best of 2025 Survey
HOUSTON, June 24, 2025 /PRNewswire/ — U.S. Legal Support, the nation's leading provider of litigation support services, proudly announces its recognition as the #1 Document Management Solution for Retrieved Records in The Recorder's Best of 2025 survey. Additionally, the company was honored with a top 3 placement in the category of Best Foreign Language Translation Provider. Developed to help lawyers identify the finest legal products and service providers, the annual Best Of supplements from recognizes vendors that lawyers and firm administrators turn to first to keep their lives on track, inside and outside of the office. These accolades reflect U.S. Legal Support's unwavering commitment to delivering innovative solutions and exceptional service to its clients in the legal industry. These prestigious awards are the result of votes from U.S. Legal Support's valued clients in the California legal community, combined with the hard work and dedication of the company's talented teams. 'We are truly honored to be recognized as the #1 Document Management Solution for Retrieved Records and a top provider of translation services,' said Jimmie Bridwell, CEO, U.S. Legal Support. 'These awards are a powerful reflection of the trust our clients and the legal community place in us, as well as the unwavering dedication of our team, who continually go above and beyond to deliver exceptional service. This accomplishment is only possible because of the incredible partnerships we've cultivated within the legal community. On behalf of the entire U.S. Legal Support team, I extend my heartfelt gratitude to our clients, partners, and colleagues for their ongoing support.' U.S. Legal Support remains committed to delivering cutting-edge solutions for medical record retrieval, organization, and management. To this end, the recently launched RecordSummary Pro service leverages cutting-edge AI technologies to streamline review and analysis with powerful medical record summaries. The thorough and accurate record summaries are organized into key sections with actionable intel and are completed in a fraction of the time and at a fraction of the traditional cost, empowering legal professionals to spend less time on manual record summarization and more time on strategic case planning. In addition to medical record retrieval solutions, U.S. Legal Support also provides a full suite of court reporting, process serving, interpreting, translations, trial services, and transcription services to law firms, insurance carriers, and corporations nationwide. To learn more, visit About U.S. Legal Support As the nation's first all-inclusive litigation support company, U.S. Legal Support provides a full suite of court reporting, process service, medical record retrieval, interpreting & translations, trial services and transcription services to law firms, enterprise legal teams, and insurance carriers nationwide. With on-demand access to 12,000+ offices in 2,700 cities and a robust digital infrastructure, we serve the legal industry better. Media Contact: media@
Malaysian Reserve
4 hours ago
- Malaysian Reserve
Exclusive Outlook: HLA Typing Market Poised for 6.7% CAGR Growth Through 2030, Reaching $1.7 Billion on Rising Transplant Demand
CHICAGO, June 24, 2025 /PRNewswire/ — The HLA Typing Market size is projected to be valued at USD 1,097.9 million in 2023 and reach USD 1.7 billion by 2030, growing at a CAGR of 6.7% according to a new report by The Research Insights. Factors such as rising use of infectious diseases and rising number of patients suffering from end-stage organ failure are fuelling the growth of the HLA typing market. Transplantation techniques have advanced over the years which has led to increase in number of people undergoing transplants and thus, increasing the demand for accurate and reliable HLA typing. Increased investments by both private and public sector on transplantation and increased awareness campaigns have encouraged more individuals to go for organ donation and transplantation. Increased focus on personalized medicine, rising advancements in molecular diagnostics and rising number of chronic disorders leading to organ failure are expected to drive the HLA typing market. The report runs an in-depth analysis of market trends, key players, and future opportunities. In general, the HLA Typing Market growth of 6.7% comprises a vast array of Product, Application, Technique, End-User and Geography which are expected to register strength during the coming years. For More Information and To Stay Updated on The Latest Developments in The Global HLA Typing Market, Download FREE Sample Pages: Market Overview and Growth Trajectory: HLA Typing Market Growth: According to an exhaustive report by The Research Insights, the HLA Typing Market is experiencing significant growth. The rapid growth of the next-generation sequencing (NGS) has led to the rising adoption of HLA typing technologies that allow for high-resolution and high-throughput HLA typing with higher accuracy. The applications of NGS have made the HLA typing more effective in transplantation and personalized medicine. The rising prevalence of autoimmune diseases and cancer has also led to a demand for precise HLA typing in immunotherapy and companion diagnostics. The increasing number of organ transplant procedures, the rising awareness of donor-recipient compatibility, and other factors have led to a consistent demand for high-end HLA matching solutions. Trends such as decentralized testing with point-of-care genetic platforms and integration of artificial intelligence for data interpretation have also influenced the market. Investments in the biopharmaceutical R&D, especially in the area of vaccine development and cell therapies, have raised the strategic importance of HLA typing in preclinical and clinical phases, and that will continue to be a major component in the evolving field of precision healthcare. The Increasing Need for Organ and Stem Cell Transplantation: The market for human leukocyte antigen (HLA) typing has seen a considerable rise due to the increasing number of organ and hematopoietic stem cell (bone marrow) transplants across the globe. HLA typing is vital in determining the compatibility between the donor and the recipient in order to reduce the chances of transplant rejection and ensure a better rate of graft survival. The prevalence of end-stage renal disease, liver failure, leukemia, lymphoma, and other immune system disorders has consistently been on the rise and has led to the demand for an increasing number of organ and stem cell transplants. According to the Global Observatory on Donation and Transplantation (GODT), the number of organ transplantations has seen a steady rise in recent years, and that of kidney and liver transplants were found to be the most in volume. HLA typing has a crucial role in the assessment before the transplantation, and therefore, is an indispensable component in the field of transplantation. The growth of transplantation registries and the awareness campaigns aimed at encouraging organ donation have also led to the increased demand for HLA testing, both for the living and the deceased. For Detailed Market Insights, Visit: Technological Advances in Molecular Diagnostics: The advances in molecular biology and genomic sequencing have helped in significantly increasing the accuracy, speed, and efficiency of HLA typing. Most of the conventional methods of serological typing have been either substituted or supported by PCR-based methods (PCR-SSP, PCR-SSO), real-time PCR, and next-generation sequencing (NGS). NGS has also offered the advantage of high-resolution typing, with deeper coverage of the HLA loci that allows the clinicians to identify the rare alleles and minimise the mismatches. Apart from this, the developments have also led to improved clinical outcomes and allowed for an expansion in the scope of personalized medicine applications, like precision immunotherapy. The use of automation and software-driven analysis tools has also helped in reducing the time of turnaround and the chance of human error, thus making HLA typing more accessible across laboratories and hospitals. The molecular diagnostics have also become more cost-effective and scalable, and therefore, the high-throughput HLA testing has been adopted in both clinical and research settings. Increasing Applications in Other Areas: Although the primary application of HLA typing is still transplantation, it has now seen increasing use in other areas as well, and that is helping to increase the demand in the market. HLA testing is being used in the field of pharmacogenomics to find the possible drug hypersensitivity reaction. 01 has been identified as a possible marker for abacavir-induced hypersensitivity, and HLA-B15:02 for carbamazepine-induced Stevens-Johnson syndrome. This has allowed the clinicians to design personalized treatment regimens and to avoid drug-induced adverse reactions, which is a primary goal of precision medicine. The HLA profiling has also found its use in autoimmune disease research, susceptibility to infectious diseases (HIV, COVID-19), and cancer immunotherapy – especially in finding the patient-specific neoantigens for the vaccine and T-cell therapy. With the increasing research in the immunogenetics and the novel therapies that are being developed, the importance of HLA typing extends beyond transplantation, and that will continue to drive the market. Stay Updated on The Latest HLA Typing Market Trends: Geographical Insights: North America holds a market share of 46.94% in the HLA typing market. The region is known for its strong academic foundation and prominent research centres, which is why it is also known for the largest contributor to the market. It is so because the rising prevalence of genetic disorders has been observed in the region, and that has led to the need for advanced healthcare facilities and research facilities. As a result, North America has one of the strongest networks of state-of-the-art medical institutions and research centres, giving it an unparalleled expertise in HLA typing. The government and industry leaders are also working to improve the organ transplantation in the region, and that has further strengthened the position of the region as the global hub for the specialized field. The Asia Pacific region is expected to witness a healthy growth in the human leukocyte antigen (HLA) typing market, as per the increasing improvements in healthcare infrastructure, comprehensive reimbursement policies, and the rising economic outlook. Presence of transplantation centers and skilled professionals will also boost the demand for HLA testing services. As laboratories continue to adopt advanced technologies, the region's HLA typing market is expected to witness substantial growth. Global HLA Typing Market Segmentation and Geographical Insights: Based on Product, the HLA Typing market is divided into, Instruments, Reagents & Consumables, and Software & Services. The human leukocyte antigen (HLA) reagents and consumables sector is poised for substantial growth, boasting a significant market share of 54.2% in 2022 and an impressive growth rate between 2023 and 2030. Based on Application, the HLA Typing market is divided into, Diagnosis, and Research. The diagnosis of Human Leukocyte Antigen (HLA) typing is poised to experience rapid growth, driven by the increasing demand for accurate disease detection. With a predicted CAGR of 6.8% over the forecast period, this segment is expected to outpace others in the market. Based on Technique, the HLA Typing market is divided into, Molecular Assay, Sequenced-based Molecular Assay, and Non-Molecular Assay. The molecular assay segment emerged as a leader in the market, boasting an impressive 53.0% share of the revenue. Based on End User, the HLA Typing market is divided into, Commercial Service Providers, Hospitals and Transplant Centres, and Research Labs & Academic Institutes. The market is predominantly driven by the growing presence of hospitals and transplant centres, accounting for a significant share of revenue, these facilities held an impressive 55.0% market stake. The HLA Typing Market is segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Purchase Premium Copy of Global HLA Typing Market Size and Growth Report (2023-2030) at: Key Players and Competitive Landscape: The Global HLA Typing Market is characterized by the presence of several major players, including: Thermo Fisher Scientific Inc. Bio-Rad Laboratories Inc. Qiagen N.V. Omixon Inc. GenDx Illumina Inc. TBG Diagnostics Limited Dickinson and Company Takara Bio Inc. F. Hoffman-La Roche Limited Pacific Biosciences These companies are adopting strategies such as new product launches, joint ventures, and geographical expansion to maintain their competitive edge in the market. Global HLA Typing Market Recent Developments and Innovations: In April 2025, Thermo Fisher Scientific launched the One Lambda HybriType Flex Kit, which aims to streamline HLA typing workflows by cutting total processing time to under 5.5 hours and hands-on time to less than 2.5 hours. In August 2024, Thermo Fisher Scientific received FDA 510(k) clearance for its SeCore CDx HLA a Sequencing System, approved as a companion diagnostic for TECELRA (afamitresgene autoleucel), a T-cell receptor therapy targeting synovial sarcoma. In October 2023, Roche launched the LightCycler PRO System based on the proven gold standard technology of the LightCycler Systems that came before it. This new system raises the bar for performance and usability while bridging the gap between translational research and in-vitro diagnostics. For Region-Specific Market Data, Check Out Brief Sample Pages: Frequently Asked Questions (FAQs): What is the forecasted market size of the HLA Typing Market in 2030?➢ The forecasted market size of the HLA Typing Market is USD 1.7 billion in 2030. Who are the leading players in the HLA Typing Market?➢ The key players in the HLA Typing Market include, Thermo Fisher Scientific Inc.; Bio-Rad Laboratories Inc.; Qiagen N.V.; Omixon Inc.; GenDx; Illumina Inc.; TBG Diagnostics Limited; Dickinson and Company; Takara Bio Inc.; F. Hoffman-La Roche Limited; and Pacific Biosciences. What are the major drivers for the HLA Typing Market? ➢ The growing need for organ transplantation and the extensive use of HLA testing in pharmacogenetics are expected to be key drivers of this growth. Which is the largest region during the forecasted period in the HLA Typing Market?➢ The North America stands out as a leader in the HLA typing market, accounting for 46.94% of the total share. Which is the largest segment, by end user, during the forecasted period in the HLA Typing Market?➢ The market is predominantly driven by the growing presence of hospitals and transplant centers, accounting for a significant share of revenue, these facilities held an impressive 55.0% market stake. Conclusion: Improvements in molecular diagnostics, next-generation sequencing (NGS), and bioinformatics are changing the HLA typing market as per the increasing need for transplantation, auto-immune diseases research, and pharmacogenomics. The increasing prevalence of chronic diseases, organ transplants, and the growing need for precision medicine have spurred the growth of high-resolution HLA typing methods. High resolution HLA typing methods can now provide increased accuracy, throughput, and speed, making them indispensable in donor-recipient matching and immunogenetic analysis. Digital platforms and cloud-based data solutions for integration help to access the analysis results in real-time and share them between institutions. The development of user-friendly software tools and automation in sample processing have helped in making laboratory workflow smooth. Along with the quality and standardization provided by the regulatory bodies, the market will continue to evolve with improved, more scalable, and cost-effective solutions. The HLA typing market will continue to be one of the major players in the growing trend of personalized medicine and advanced immunological research. Need A Diverse Region or Sector? Customize Research to Suit Your Requirement: The report from The Research Insights, therefore, provides several stakeholders— healthcare providers, diagnostic laboratories, research institutions, regulatory agencies, and patients —with valuable insights into how to successfully navigate this evolving market landscape and unlock new opportunities. With projected growth to US$ 1.7 billion by 2030, the Global HLA Typing Market represents a significant opportunity for biotech startups, software developers, data analytics firms, and AI technology providers, can position themselves for success in this dynamic and evolving market landscape. Check out more related studies published by The Research Insights: Personalized Medicine Market: The Global Personalized Medicine Market is expected to reach at USD 909.80 billion by 2030, according to a new report by The Research Insights. It is projected to expand at a CAGR of 8.2% during the forecast period. The rising prevalence of cancers and other diseases worldwide is driving the demand for innovative drug discovery solutions, a key factor contributing to the market's growth. Next-generation Sequencing Services Market – The global next-generation sequencing services market is poised to experience significant expansion, with an estimated USD 5.89 billion in revenue in 2023. At a compound annual growth rate (CAGR) of 22.68% from 2024 to 2030, the market is expected to continue growing rapidly. The integration of next-generation sequencing (NGS) technology into various applications has become increasingly widespread, enabling rapid and comprehensive insights at a genomic level. Browse More related reports on Healthcare Industry Market Reports – About Us: The Research Insights provides thoroughly conducted research which is backed up by real-time statistics and data. Our experts are eager to help you with any information required under the sun. The key to our success is keeping abreast with the markets, industries, and ever-changing consumer trends that matter. Our market research professionals have in-depth knowledge and expertise across various domains that includes IT and Telecom, Emerging Technologies, Consumer Offerings, Manufacturing and Others. We are committed to reviewing the scope and procedure of the research studies that you select and provide you with an accurate guidance in order to assist you in taking the correct business decisions. Contact Us:If you have any queries about this report or if you would like further information, please contact us: Contact Person: Kaushik RoyE-mail: sales@ +1-312-313-8080Blog: Press Release: Latest News: | Logo: View original content:
The Sun
6 hours ago
- The Sun
Poor posture from phone use causing health issues in Malaysians
PETALING JAYA: Malaysians, particularly youth and office workers, are increasingly grappling with posture-related health issues due to excessive phone and digital device use, said Physiogo trainer and physiotherapist Nor Izzah Lukman. 'At Physiogo, over 50% of our clients report neck pain. One of the main contributing factors is poor posture, especially when the head is tilted forward for prolonged periods while using phones.' She said common complaints include 'text neck', shoulder tension and lower back pain. She also said the problem worsened during the Covid-19 pandemic as remote work and online learning drastically increased daily screen time. The most prevalent posture-related conditions include lower back pain, forward neck flexion and shoulder strain, all linked to prolonged sitting and poor spinal alignment. 'When the lumbar sitting angle drops below 90°, it could compress the lumbar nerve roots, leading to pain and nerve irritation,' she explained. Citing research from the Universiti Malaya Medical Centre, she noted that 60% of office workers aged between 30 and 50 experience musculoskeletal pain. 'Among younger adults aged between 18 and 30, technology use is the main culprit, while older adults tend to suffer due to years of poor posture and age-related degeneration. 'Women may develop posture issues from pregnancy or osteoporosis while men are more prone to injuries from physical labour or extended sitting,' she added. Nor Izzah highlighted a rise in cases of dropped head syndrome (DHS) in which severe weakness in the neck extensor muscles causes the head to droop forward. 'DHS is typically linked to neuromuscular disorders, such as amyotrophic lateral sclerosis. Another variant, isolated neck extensor myopathy, is sometimes seen in elderly patients with spinal deformities such as kyphosis.' She warned that poor ergonomics, such as constantly looking down at phones or using laptops without proper alignment, could result in tension headaches, shoulder tightness and even nerve compression, leading to tingling sensations in the arms. She recommended keeping screens at eye level, maintaining proper back support and sitting with elbows at a 90° angle. 'Follow the 20-20-20 rule, every 20 minutes, look at something 20 feet away for 20 seconds. Also, take a break every 30 to 60 minutes to stretch.' Simple exercises, such as chin tucks, neck stretches and shoulder rolls, could relieve tension and improve posture. 'Neglecting these habits may lead to chronic conditions, such as disc degeneration or myofascial pain,' she warned. She called for greater public awareness through social media campaigns, infographics and stretching tutorials. 'Education should start early, with school talks that promote healthy posture habits from a young age.' Orthopaedic specialist Dr Rabeenash Singh Rajpal Singh, part of the spine team at Hospital Putrajaya, outlined the key causes of DHS, namely neuromuscular disorders such as myasthenia gravis, structural deformities such as scoliosis and kyphosis, and degenerative or postural issues such as cervical spondylosis. He added that patients who have undergone radiation therapy for thyroid or neck cancers may develop DHS due to muscle and nerve damage. 'Scoliosis and kyphosis, often diagnosed during adolescence, can worsen over time if not treated,' he said. He said while physiotherapy may help in mild cases, severe spinal deformities may require surgical correction to restore alignment. He explained that cervical spondylosis, caused by disc wear and tear, could compress nerves and trigger pain in the neck and arms, although it typically does not lead to full head drooping as seen in DHS. Early signs of DHS include numbness or tingling in the hands, neck stiffness and muscle weakness during simple tasks, such as brushing teeth. 'These red flags are often ignored until more serious complications occur, such as mobility loss or bladder dysfunction,' he cautioned. Rabeenash advised maintaining a healthy weight, eating well and staying physically active. 'Strengthening core muscles with exercises such as Pilates is especially beneficial.' He warned against long hours of sitting with poor posture. 'Sit upright, do not slouch and avoid hunching over devices. These small changes could make a big difference in long-term spinal health.'
